- Home
- IOVA vs FINW Comparison
IOVA vs FINW Comparison
Compare IOVA & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- FINW
- Stock Information
- Founded
- IOVA 2007
- FINW 1999
- Country
- IOVA United States
- FINW United States
- Employees
- IOVA N/A
- FINW N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- FINW Commercial Banks
- Sector
- IOVA Health Care
- FINW Finance
- Exchange
- IOVA Nasdaq
- FINW Nasdaq
- Market Cap
- IOVA 1.0B
- FINW 192.3M
- IPO Year
- IOVA N/A
- FINW 2021
- Fundamental
- Price
- IOVA $1.75
- FINW $14.58
- Analyst Decision
- IOVA Strong Buy
- FINW Buy
- Analyst Count
- IOVA 9
- FINW 4
- Target Price
- IOVA $15.50
- FINW $20.75
- AVG Volume (30 Days)
- IOVA 13.9M
- FINW 24.7K
- Earning Date
- IOVA 05-08-2025
- FINW 04-30-2025
- Dividend Yield
- IOVA N/A
- FINW N/A
- EPS Growth
- IOVA N/A
- FINW N/A
- EPS
- IOVA N/A
- FINW 0.91
- Revenue
- IOVA $212,679,000.00
- FINW $72,056,000.00
- Revenue This Year
- IOVA $182.20
- FINW $43.72
- Revenue Next Year
- IOVA $62.10
- FINW $21.32
- P/E Ratio
- IOVA N/A
- FINW $16.22
- Revenue Growth
- IOVA 11070.12
- FINW 8.59
- 52 Week Low
- IOVA $2.70
- FINW $10.02
- 52 Week High
- IOVA $13.60
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- IOVA 23.78
- FINW 43.61
- Support Level
- IOVA $3.02
- FINW $13.49
- Resistance Level
- IOVA $3.31
- FINW $14.66
- Average True Range (ATR)
- IOVA 0.24
- FINW 0.69
- MACD
- IOVA -0.09
- FINW 0.03
- Stochastic Oscillator
- IOVA 4.81
- FINW 36.56
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.